Eton Pharmaceuticals Inc (ETON) Directors and Executive Officers

Officers & Directors

James Gruber
Chief Financial Officer, Treasurer and Secretary

Paul V. Maier
Director

Charles J. Casamento
Director

Sean E. Brynjelsen
President and Chief Executive Officer (Principal Executive Officer)

Norbert G. Riedel, Ph.D.
Director

Jennifer M. Adams
Director ,

Eton Pharmaceuticals Inc currently has 44 employees.

News about Eton Pharmaceuticals Inc Key Personnel

Eton Pharmaceuticals' Hydrocortisone Oral Solution Prepares for FDA Decision as Share Price Rises

In an exciting development for Eton Pharmaceuticals, the company recently announced that the U.S. Food and Drug Administration (FDA) has accepted their New Drug Application (NDA) for ET-400, a Hydrocortisone Oral Solution. The Prescription Drug User Fee Act (PDUFA) target action date for the drug s approval is set for February 28, 2025. As Eton anticipates this decisive date, investors have taken notice, driving ETON shares to a notable 4.57% increase in the last five trading days. Let us delve into the upcoming FDA decision and the reasons behind Eton s soaring stock performance.
The Promise of Hydrocortisone Oral Solution:
ET-400, Eton Pharmaceuticals Hydrocortisone Oral Solution, holds ...